Načítá se...
Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature
The use of intravitreal antivascular endothelial growth factor (anti-VEGF) injection is gaining wide acceptance as an off-label therapy for diseases that may affect pregnant women. However, these drugs may cause systemic side effects in the mother and fetal harm. This could lead specialists to not a...
Uloženo v:
| Vydáno v: | J Ocul Pharmacol Ther |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mary Ann Liebert, Inc.
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4677108/ https://ncbi.nlm.nih.gov/pubmed/26302032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2015.0056 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|